Success Metrics

Clinical Success Rate
91.4%

Based on 32 completed trials

Completion Rate
91%(32/35)
Active Trials
4(8%)
Results Posted
13%(4 trials)
Terminated
3(6%)

Phase Distribution

Ph not_applicable
6
12%
Ph phase_3
7
14%
Ph phase_2
17
35%
Ph phase_1
7
14%
Ph phase_4
11
22%

Phase Distribution

7

Early Stage

17

Mid Stage

18

Late Stage

Phase Distribution48 total trials
Phase 1Safety & dosage
7(14.6%)
Phase 2Efficacy & side effects
17(35.4%)
Phase 3Large-scale testing
7(14.6%)
Phase 4Post-market surveillance
11(22.9%)
N/ANon-phased studies
6(12.5%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

88.9%

32 of 36 finished

Non-Completion Rate

11.1%

4 ended early

Currently Active

4

trials recruiting

Total Trials

49

all time

Status Distribution
Active(6)
Completed(32)
Terminated(4)
Other(7)

Detailed Status

Completed32
unknown7
Terminated3
Active, not recruiting2
Not yet recruiting2
Recruiting2

Development Timeline

Analytics

Development Status

Total Trials
49
Active
4
Success Rate
91.4%
Most Advanced
Phase 4

Trials by Phase

Phase 17 (14.6%)
Phase 217 (35.4%)
Phase 37 (14.6%)
Phase 411 (22.9%)
N/A6 (12.5%)

Trials by Status

unknown714%
withdrawn12%
terminated36%
completed3265%
active_not_recruiting24%
not_yet_recruiting24%
recruiting24%

Recent Activity

Clinical Trials (49)

Showing 20 of 49 trialsScroll for more
NCT06872112Phase 1

A Study Evaluating the Safety and Tolerability of Artesunate in Patients With Pulmonary Arterial Hypertension

Recruiting
NCT05750459Phase 4

Pharmacokinetic Study of IV Artesunate to Treat Children With Severe Malaria

Completed
NCT06853184Phase 2

Study Evaluating the Efficacy and Safety of Artesunate

Recruiting
NCT07022743Phase 2

Improving Treatment Outcomes in Chronic Myeloid Leukaemia Patients Using Imatinib and Artesunate Combination Therapy

Active Not Recruiting
NCT07095309Phase 2

Safety and Effectiveness Study of Pre-operative Artesunate in Stage II/ III Colorectal Cancer

Not Yet Recruiting
NCT07095478Phase 2

Safety and Efficacy of Oral Artesunate for Pre-cervical Cancer

Not Yet Recruiting
NCT05555862Phase 2

Artesunate Suppositories for the Treatment of HIV-negative Patients With Intra-anal HSIL

Active Not Recruiting
NCT04706130Phase 4

Rigorous Assessment of P. Vivax Relapses and Primaquine Efficacy for Radical Cure

Completed
NCT06294912Phase 1

A Study to Evaluate Antimalarial Activity and Safety of MK-7602 in Healthy Adults (MK-7602-003)

Completed
NCT04330690Phase 3

Treatments for COVID-19: Canadian Arm of the SOLIDARITY Trial

Unknown
NCT04713631Phase 2

Safety and Efficacy of Artesunate & Curcumin in Crohn's Disease

Unknown
NCT04374019Phase 2

Novel Agents for Treatment of High-risk COVID-19 Positive Patients

Terminated
NCT00356824

Relationship Between HIV and Malaria in Ugandan Children

Completed
NCT02304289Phase 1

Dose-Escalation Study Evaluating the Safety and Pharmacokinetics of Artesunate in Patients With Hepatocellular Carcinoma

Terminated
NCT03214731Phase 4

Efficacy and Safety of Artesunate Plus Standard of Care in Active Lupus Nephritis

Unknown
NCT02084602Phase 4

Assessment of Artesunate/Mefloquine in the Peruvian Amazon

Completed
NCT02996695Phase 1

Safety and Efficacy of Sanaria's PfSPZ-CVac in Malian Adults

Completed
NCT00298610Phase 2

Safety and Efficacy Study of IV Artesunate to Treat Malaria

Completed
NCT02663700Phase 1

Safety and Immunogenicity of Sanaria's Irradiated Sporozoite Vaccine (PfSPZ Vaccine) in Malaria-Experienced Adults in Burkina Faso

Completed
NCT00936767Phase 2

Artemisone for the Treatment of Uncomplicated Falciparum Malaria in Western Cambodia

Withdrawn

Drug Details

Intervention Type
DRUG
Total Trials
49